Anti-Borrelia IgG Seropositivity Among Hemodialysis Patients with Chronic Kidney Disease of Unknown Etiology: A Preliminary Case–Control Study from Northern Türkiye
Pathogens · 22.06.2026 · 15 (6) · 655
DOI: 10.3390/pathogens15060655 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 22.06.2026. Verfasst von Eşe Aslan Başbulut und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Samsun Training and Research Hospital, Health Science University, Samsun 55090, Türkiye. Hauptthemen laut MEDLINE: Antibodies, Bacterial, Immunoglobulin G, Lyme Disease, Renal Dialysis. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lyme borreliosis is a multisystemic tick-borne infection caused by Borrelia burgdorferi sensu lato complex. Renal involvement is well documented in dogs with Lyme nephritis, whereas human renal manifestations have been reported only rarely, mainly as isolated case reports of glomerular disease. Because a proportion of chronic kidney disease (CKD) cases remain unexplained, we aimed to determine the possible contribution of previous exposure to idiopathic CKD.
Methods
The study included 45 patients and 45 age and sex matched controls. Serum samples were tested for anti-Borrelia IgG using enzyme-linked immunosorbent assay (ELISA). Positive or borderline ELISA results were further evaluated by Western blot (WB) analysis.
Results
Overall, anti-Borrelia IgG seropositivity was 5.55% with WB. In the CKD group, ELISA positivity was 11.1% and WB-confirmed positivity was 8.9%. In the control group, ELISA positivity was 4.4% and WB-confirmed positivity was 2.2%. (p > 0.05). All confirmed patients were living in rural areas, engaged in farming and/or animal husbandry, and reported repeated tick exposure.
Conclusions
IgG seropositivity was numerically higher among patients with CKD of unknown etiology than among healthy controls; however, this difference was not statistically significant. Larger, risk-factor-adjusted studies are needed to clarify whether Borrelia exposure may be associated with unexplained CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Samsun Training and Research Hospital, Health Science University, Samsun 55090, Türkiye.
- Department of Nephrology, Faculty of Medicine, Samsun University, Samsun 55090, Türkiye.
- Department of Clinical Microbiology, Faculty of Medicine, Ahi Evran University, Kirsehir 40100, Türkiye.
ORCID-Profile: Eşe Aslan Başbulut, Demet Yavuz
Zitieren
APA
Aslan Başbulut, E., Yavuz, D., & Demir, T. (2026). Anti-Borrelia IgG Seropositivity Among Hemodialysis Patients with Chronic Kidney Disease of Unknown Etiology: A Preliminary Case–Control Study from Northern Türkiye. Pathogens, 15(6), 655. https://doi.org/10.3390/pathogens15060655
Vancouver
Aslan Başbulut E, Yavuz D, Demir T. Anti-Borrelia IgG Seropositivity Among Hemodialysis Patients with Chronic Kidney Disease of Unknown Etiology: A Preliminary Case–Control Study from Northern Türkiye. Pathogens. 2026;15(6):655. doi:10.3390/pathogens15060655
BibTeX
@article{AslanBabulut2026,
author = {Aslan Başbulut, Eşe and Yavuz, Demet and Demir, Tülin},
title = {Anti-Borrelia IgG Seropositivity Among Hemodialysis Patients with Chronic Kidney Disease of Unknown Etiology: A Preliminary Case–Control Study from Northern Türkiye},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {6},
pages = {655},
doi = {10.3390/pathogens15060655}
}
EUVIMED